In retrospective studies, researchers found that low expression of Slit2 in breast cancer and pancreatic ductal adenocarcinoma (PDAC) patients were both associated with higher incidence and a higher extent of lymph node metastasis14, 15. Here, SLIT2 is linked to pancreatic ductal adenocarcinoma.